MIF and breast cancer: The serum level of MIF was significantly increased in the BC cases in comparison to the control subjects (p < 0.0001), with a diagnostic potential to discriminate BC with a sensitivity of 92.5% and a specificity of 73.7% at a cut-off value > 9.47 ng/mL (Fig. 1).